Related Experiment Video
Updated: Sep 8, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive
Jiyoung Lee1, Cristina Olivieri2, Colin Ong1
1Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637.
Abstract:
Raf Kinase Inhibitory Protein (RKIP) maintains cellular robustness and prevents the progression of diseases such as cancer and heart disease by regulating key kinase cascades including MAP kinase and protein kinase A (PKA). Phosphorylation of RKIP at S153 by Protein Kinase C (PKC) triggers a switch from inhibition of Raf to inhibition of the G protein coupled receptor kinase 2 (GRK2), enhancing signaling by the β-adrenergic receptor (β-AR) that activates PKA. Here we report that PKA-phosphorylated RKIP promotes β-AR-activated PKA signaling. Using biochemical, genetic, and biophysical approaches, we show that PKA phosphorylates RKIP at S51, increasing S153 phosphorylation by PKC and thereby triggering feedback activation of PKA. The S51V mutation blocks the ability of RKIP to activate PKA in prostate cancer cells and to induce contraction in primary cardiac myocytes in response to the β-AR activator isoproterenol, illustrating the functional importance of this positive feedback circuit. As previously shown for other kinases, phosphorylation of RKIP at S51 by PKA is enhanced upon RKIP destabilization by the P74L mutation. These results suggest that PKA phosphorylation at S51 may lead to allosteric changes associated with a higher-energy RKIP state that potentiates phosphorylation of RKIP at other key sites. This allosteric regulatory mechanism may have therapeutic potential for regulating PKA signaling in disease states.
Insights
Protein Kinase A (PKA) phosphorylates Raf Kinase Inhibitory Protein (RKIP) at S51, creating a positive feedback loop that enhances PKA signaling. This RKIP regulation is crucial for cellular robustness and disease prevention.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Raf Kinase Inhibitory Protein (RKIP) is vital for cellular robustness, regulating kinase cascades like MAP kinase and Protein Kinase A (PKA).
- PKC-mediated phosphorylation of RKIP at S153 switches its target from Raf to GRK2, enhancing β-adrenergic receptor (β-AR) signaling and PKA activation.
Purpose of the Study:
- To investigate the role of PKA in RKIP phosphorylation and its impact on PKA signaling pathways.
- To elucidate the feedback mechanisms involving RKIP phosphorylation in cellular signaling.
Main Methods:
- Biochemical assays
- Genetic manipulation (S51V mutation)
- Biophysical techniques
- Cellular studies (prostate cancer cells)
- Primary cardiac myocyte studies
Main Results:
- PKA phosphorylates RKIP at S51, which in turn increases S153 phosphorylation by PKC.
- This PKA-mediated phosphorylation at S51 creates a positive feedback loop, amplifying PKA signaling.
- The S51V mutation in RKIP abrogates PKA activation and impairs cardiac myocyte contraction in response to β-AR stimulation.
- PKA phosphorylation at S51 is enhanced by RKIP destabilization (P74L mutation), suggesting allosteric regulation.
Conclusions:
- PKA-phosphorylated RKIP at S51 acts as a crucial positive feedback regulator of PKA signaling.
- This allosteric mechanism highlights a novel regulatory circuit with potential therapeutic implications for diseases involving PKA dysregulation.
- RKIP phosphorylation dynamics are critical for maintaining cellular signaling fidelity and preventing disease progression.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

